Abstract
8121 Background: The role of maintenance therapy in the management of multiple myeloma remains unclear. Methods: TT3 applied 3 years of maintenance therapy with VTD in year 1 and TD in years 2 and ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
